Cargando…

BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor

PURPOSE: The importance of long noncoding RNAs (lncRNAs) in tumorigenesis has recently been demonstrated. However, the role of lncRNAs in development of thyroid cancer remains largely unknown. MATERIALS AND METHODS: Using quantitative reverse transcription polymerase chain reaction, expression of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Haitao, Wang, Meng, Jiang, Lixin, Chu, Haidi, Hu, Jinchen, Ning, Jinyao, Li, Baoyuan, Wang, Dong, Xu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843736/ https://www.ncbi.nlm.nih.gov/pubmed/26323637 http://dx.doi.org/10.4143/crt.2015.118

Ejemplares similares

B-Raf mutation and papillary thyroid carcinoma patients
por: JIANG, LIXIN, et al.
Publicado: (2016)

Pin1 is related with clinical stage of papillary thyroid carcinoma
por: Jiang, Lixin, et al.
Publicado: (2016)

Correlation of thyroid stimulating hormone receptor mRNA expression levels in peripheral blood with undesirable clinicopathological features in papillary thyroid carcinoma patients
por: Liu, Riming, et al.
Publicado: (2017)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Emodin inhibits the proliferation of papillary thyroid carcinoma by activating AMPK
por: Li, Weilong, et al.
Publicado: (2021)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

Reactivity of thyroid papillary carcinoma cells to thyroid stimulating hormone-dominated endocrine therapy
por: Ma, Yuqin, et al.
Publicado: (2017)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
por: Xu, Bin, et al.
Publicado: (2023)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

Expression and Clinical Significance of Thyroid-stimulating hormone receptor in the Subtypes of Papillary thyroid carcinomas
por: Shen, Wei, et al.
Publicado: (2023)

BRAF(V600E) mutation contributes papillary thyroid carcinoma and Hashimoto thyroiditis with resistance to thyroid hormone: A case report and literature review
por: Xing, Wanjia, et al.
Publicado: (2017)

Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
por: Issa, Peter P., et al.
Publicado: (2022)

Coexistence of resistance to thyroid hormone and papillary thyroid carcinoma
por: Igata, Motoyuki, et al.
Publicado: (2016)

Thyroid Hormone Resistance With Concurrent Papillary Thyroid Cancer
por: Pahwa, Dhivya, et al.
Publicado: (2021)

Identification of Long Noncoding RNAs Associated With the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated With Hashimoto’s Thyroiditis
por: Zhang, Yu, et al.
Publicado: (2022)

Relationship Between Thyroid-Stimulating Hormone Level and Aggressive Pathological Features of Papillary Thyroid Cancer
por: Demircioglu, Zeynep Gul, et al.
Publicado: (2022)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
por: Li, Qian, et al.
Publicado: (2017)

BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma
por: WANG, YONG, et al.
Publicado: (2014)

Expression and Function of Long Noncoding RNA NONHSAT129183 in Papillary Thyroid Cancer
por: Ding, Jian, et al.
Publicado: (2018)

Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
por: Lee, Myung-Chul, et al.
Publicado: (2019)

Long noncoding RNA XIST promotes proliferation and invasion by targeting miR-141 in papillary thyroid carcinoma
por: Xu, Yawei, et al.
Publicado: (2018)

The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients
por: Yang, Li-Bo, et al.
Publicado: (2015)

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma
por: Henke, Lauren E, et al.
Publicado: (2015)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates
por: Al-Salam, Suhail, et al.
Publicado: (2020)

BRAF and TERT mutations in papillary thyroid cancer patients of Latino ancestry
por: Estrada-Flórez, Ana P, et al.
Publicado: (2019)

BRAF V600E and lymph node metastases in papillary thyroid cancer
por: Chen, Pan, et al.
Publicado: (2020)

Patterns and clinical significance of cervical lymph node metastasis in papillary thyroid cancer patients with Delphian lymph node metastasis
por: Zheng, Guibin, et al.
Publicado: (2017)

Identification of Long Noncoding RNAs Deregulated in Papillary Thyroid Cancer and Correlated with BRAF(V600E) Mutation by Bioinformatics Integrative Analysis
por: Goedert, Lucas, et al.
Publicado: (2017)

Insulin‐like growth factor 1 promotes proliferation and invasion of papillary thyroid cancer through the STAT3 pathway
por: Yang, Li, et al.
Publicado: (2020)

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer
por: Liao, Tian, et al.
Publicado: (2016)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
por: Yan, Changjiao, et al.
Publicado: (2019)

Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma
por: Zhou, Changxin, et al.
Publicado: (2019)

Sensitivity to thyroid hormone indices are associated with papillary thyroid carcinoma in Chinese patients with thyroid nodules
por: Sun, Jie, et al.
Publicado: (2023)

Goitrogenic Anions, Thyroid-Stimulating Hormone, and Thyroid Hormone in Infants
por: Cao, Yang, et al.
Publicado: (2010)

Squamous Cell Carcinoma of the Thyroid as a Result of Anaplastic Transformation from BRAF-Positive Papillary Thyroid Cancer
por: Basnet, Alina, et al.
Publicado: (2017)

Risk and Prognostic Factors for BRAF(V600E) Mutations in Papillary Thyroid Carcinoma
por: Wei, Xiaojing, et al.
Publicado: (2022)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma
por: HE, GUOPING, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rui9v0u2beonu75kvmcgibipc7